In Brief: New Benzodiazepine Warnings

Date: November 2, 2020 Issue #:  1610Summary:  The FDA now requires boxed warnings in the package inserts of benzodiazepines describing the potential for these drugs to be abused and misused and to cause addiction and physical dependence. Benzodiazepine labels have contained a boxed warning about a risk of serious drug interactions with opioids since 2016.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: Source Type: research